Ignite Creation Date:
2025-12-24 @ 11:13 PM
Ignite Modification Date:
2026-05-20 @ 8:36 AM
Study NCT ID:
NCT05523869
Status:
RECRUITING
Last Update Posted:
2025-02-11
First Post:
2022-08-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment with Proliferative Vitreoretinopathy
Sponsor:
Unity Health Toronto
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TOPO-RD
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None